Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TUBectomy With Delayed Oophorectomy as Alternative for Risk-reducing Salpingo-oophorectomy in High Risk Women to Assess the Safety of Prevention: TUBA-WISP II Study.

NCT04294927 is registered in ClinicalTrials.gov with University Medical Center Nijmegen as lead sponsor.

NCT NCT04294927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04294927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TUBectomy With Delayed Oophorectomy as Alternative for Risk-reducing Salpingo-oophorectomy in High Risk Women to Assess the Safety of Prevention: TUBA-WISP II Study.
Lead sponsor
University Medical Center Nijmegen
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2020
Completion date
February 17, 2040
Enrollment
3,000 (estimated)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 gene mutation, brca2 gene mutation, brip1 gene mutation, ovarian cancer, rad51c gene mutation, rad51d gene mutation